lung cancer

Lung Cancer Genomic Mapping Yields New Targets, Researchers Say
Bloomberg
Mon, 09/10/12 - 10:43 am
genomic mapping
lung cancer
Pfizer
Iressa
Roche
Tarceva
UK Hospitals Commence Advanced Stereotactic Lung Cancer Treatments Using RapidArc Radiosurgery
Thu, 09/6/12 - 08:35 pm
UK
Hospital
Europe
lung cancer
cancer
radiosurgery
surgical
Varian Medical
Lilly lung cancer drug fails to meet main goal in Phase 3 study
Reuters
Thu, 09/6/12 - 10:07 am
Alimta
lung cancer
Eli Lilly
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Fri, 08/31/12 - 12:27 pm
tivantinib
Arqule
lung cancer
Tarceva
Roche
Astellas
ArQule Shares Drop on Lung Cancer Drug Safety Concern
Minyanville
Wed, 08/29/12 - 12:17 pm
Arqule
lung cancer
tivantinib
Court sides with Lilly over cancer drug patent
Yahoo/AP
Fri, 08/24/12 - 05:54 pm
patents
Eli Lilly
Alimta
mesothelioma
lung cancer
Pfizer lung cancer drug achieves Phase 3 endpoint
Marketwatch
Tue, 06/19/12 - 10:15 am
Pfizer
lung cancer
Xalkori
Bristol Immune Drug Success In Cancer May Spur Industry Race
Bloomberg
Mon, 06/4/12 - 06:03 pm
Bristol-Myers Squibb
lung cancer
skin cancer
kidney cancer
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bloomberg
Sun, 06/3/12 - 11:18 am
skin cancer
Bristol-Myers Squibb
BMS-936558
kidney cancer
lung cancer
Bristol Drug Seen Helping Body Attack Lung Cancer: Health
Bloomberg
Wed, 05/30/12 - 10:21 am
Bristol-Myers Squibb
BMS-936558
lung cancer
Nexavar: Are 3 Failed Phase 3 Trials Enough?
Motley Fool
Thu, 05/24/12 - 10:13 am
Bayer
Onyx
Nexavar
lung cancer
Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Yahoo/AP
Tue, 05/22/12 - 09:42 am
Bayer
Onyx
Nexavar
lung cancer
US FDA okays Ambit Biosciences & Teva's IND for CEP-32496, a novel BRAF inhibitor
Pharmabiz
Sat, 05/19/12 - 12:26 pm
Ambit Biosciences
Teva Pharmaceuticals
CEP-32496
cancer
melanoma
lung cancer
thyroid cancer
colon cancer
ovarian cancer
Array shares rise on lung cancer, melanoma results
Reuters
Thu, 05/17/12 - 10:32 am
lung cancer
melanoma
Array Biopharma
selumetinib
Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Lung Cancer
Yahoo/Reuters
Thu, 12/22/11 - 07:57 am
Geron
lung cancer
brain metastases
GRN1005
Peregrine's Lung Cancer Drug Has Promising Trial
Seeking Alpha
Wed, 12/7/11 - 04:53 pm
lung cancer
Peregrine Pharmaceuticals
bavituximab
Pfizer's Xalkori: The Story Can Only Get Better
Seeking Alpha
Mon, 11/28/11 - 04:44 pm
Pfizer
Xalkori
lung cancer
AstraZeneca Victory Over Iressa Labeling Is Appealed
Pharmalot
Mon, 11/28/11 - 09:57 am
AstraZeneca
Iressa
lung cancer
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thu, 10/27/11 - 01:40 pm
vaccines
ICT-107
glioblastoma
ImmunoCellular
VGX-3100
Inovio
cervical cancer
MAGE-A3
GSK
skin cancer
lung cancer
NeuVax
breast cancer
RXi Pharmaceuticals
Antigen Express
AE37
Nexvax2
celiac disease
ImmusanT
ADXS-HPV
head and neck cancer
Advaxis
GI-4000
GlobeImmune
pancreatic cancer
PEV7
Pevion Biotech
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Yahoo/AP
Fri, 09/30/11 - 11:09 am
Array
lung cancer
selumetinib
AstraZeneca

Pages